Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect on Migraine Frequency of Combined Anti-oxidant Therapy: N-acetylcysteine, Vitamin E and Vitamin C (NEC): The MIGRANT Study

NCT02629536 is registered in ClinicalTrials.gov with University of Notre Dame Australia as lead sponsor.

NCT NCT02629536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02629536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect on Migraine Frequency of Combined Anti-oxidant Therapy: N-acetylcysteine, Vitamin E and Vitamin C (NEC): The MIGRANT Study
Lead sponsor
University of Notre Dame Australia
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2016
Completion date
March 31, 2017
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, headaches